arrow
L

Lise Lotte Gluud

University of Copenhagen
H指数:73
被引数:2.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Proteomic profiling of liver and plasma uncovers biomarkers and mechanisms in patients with primary biliary cholangitis

肝脏和血浆的蛋白质组学分析揭示了原发性胆汁性胆管炎患者中的生物标志物和机制

2026-10-010
OAAI
An LC-MS/MS assay for quantification of plasma biomarkers to assess transporter-mediated drug-drug interactions and biomarker baselines in healthy volunteers

一种用于评估转运体介导的药物-药物相互作用和生物标志物基线的血浆生物标志物定量LC-MS/MS分析方法

2026-09-280
OAAI
Investigation of non-invasive tests for fibrosis diagnosis and prognostication of events in metabolic dysfunction-associated steatotic liver disease: A prospective study cohort

代谢功能障碍相关脂肪性肝病中非侵入性检查对纤维化诊断和事件预后的研究:一项前瞻性队列研究

2026-09-010
OAAI
Arachidonoyl-taurine is elevated in human MASLD and protects against hepatic steatosis and inflammation in preclinical models

花生四烯酰-牛磺酸在人类MASLD中升高,并在临床前模型中保护肝脏脂肪变性和炎症

2026-05-090
OAAI
Collagen proportionate area and histological grading of fibrosis as predictors of clinical outcomes and mortality in patients with steatotic liver disease

胶原蛋白比例面积和纤维化组织学分级作为预测脂肪性肝病患者临床结局和死亡率的风险因素。

2026-01-020
OAAI
Effects of zibotentan and dapagliflozin combined in patients with compensated cirrhosis: A randomized placebo-controlled exploratory study

zibotentan和dapagliflozin联合治疗代偿期肝硬化患者的效果:一项随机、安慰剂对照的探索性研究

2025-12-010
PRE
Metabolic dysfunction-associated steatotic liver disease, cardiometabolic risk factors, and cardiac manifestations in psoriasis: A cross-sectional study of 255 patients

代谢功能障碍相关脂肪性肝病、心血管代谢危险因素及银屑病中心脏表现:一项包含255名患者的横断面研究

2025-11-300
PRE
Pre-emptive TIPS should be considered in high-risk patients with both acute variceal bleeding and severe alcohol-related hepatitis

对于同时患有急性静脉曲张出血和严重酒精性肝病的危重患者,应考虑进行预防性TIPS治疗。

2025-09-290
OAAI
Alterations in one-carbon metabolism in metabolic dysfunction associated steatotic liver disease may be modified by semaglutide

代谢功能障碍相关脂肪性肝病中的一碳代谢改变可能被司美格鲁肽所修饰。

2025-08-300
OAAI
Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis

通过司美格鲁肽对代谢功能障碍相关脂肪性肝炎中代谢、炎症和纤维化通路的调控

2025-07-210
OAAI
Genome-wide meta-analysis identifies nine loci to be associated with higher risk of hepatocellular carcinoma development.

全基因组荟萃分析确定了九个位点与肝细胞癌发展的更高风险相关。

2025-06-010
OAAI
Development of ROBUST-RCT: Risk Of Bias instrument for Use in SysTematic reviews-for Randomised Controlled Trials

ROBUST-RCT的开发:用于系统评价的随机对照试验偏倚风险评估工具

2025-03-250
PRE